Frailty Is Inversely Related to Age at Menopause and Elevated in Women Who Have Had a Hysterectomy: An Analysis of the Canadian Longitudinal Study on Aging
- 23 April 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 74 (5) , 675-682
Abstract
Frailty is a complex pathophysiological phenomenon that will impact a significant proportion of adults over the age of 65 and contributes to the risk of several adverse health outcomes. Although women have a disproportionately higher risk of frailty, the sex-specific factors related to this syndrome are not well described. Hence, we sought to examine the relationship of age at menopause, hysterectomy status, and hormone replacement therapy use with prevalent frailty in older women. We performed a cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA) Baseline Comprehensive Cohort (n = 30,097, 45–85 years old). Frailty was operationalized using both the deficit accumulation (frailty index) and frailty phenotype (Fried) models. Postmenopausal women were categorized as follows: premature (30–39 years), early (40–45 years), normal (46–54 years), and late (55+ years) menopause, or hysterectomy. Associations were determined using multivariate analysis, adjusting for sociodemographics, lifestyle factors, social support, and hormone replacement therapy use. Age at menopause was inversely related to frailty in older Canadian women. The frailty index decreased 1.2% of the mean (p < .001) with every year of menopause onset and was significantly higher for women in the premature (24%; p < .001) and early (7%; p < .01) menopause and hysterectomy (21%; p < .001) groups, compared to the normal menopause group. The odds for being classified as frail using Fried’s criteria was higher for the premature menopause (OR = 1.33, 95% CI = 0.72–2.27) and hysterectomy (OR = 1.59, 95% CI = 1.25–2.02) groups. Our study supports a role for age at menopause and hysterectomy in the risk of frailty in older women and warrants further investigation.Keywords
Funding Information
- Government of Canada
- Canadian Institutes of Health Research (LSA 9447)
- Canada Foundation for Innovation
This publication has 36 references indexed in Scilit:
- Frailty Consensus: A Call to ActionJournal of the American Medical Directors Association, 2013
- Endocrinology of the aging maleBest Practice & Research Clinical Endocrinology & Metabolism, 2011
- Prevalence and 10‐Year Outcomes of Frailty in Older Adults in Relation to Deficit AccumulationJournal of the American Geriatrics Society, 2010
- The Canadian Longitudinal Study on Aging (CLSA)Canadian Journal on Aging / La Revue canadienne du vieillissement, 2009
- A standard procedure for creating a frailty indexBMC Geriatrics, 2008
- Social Vulnerability, Frailty and Mortality in Elderly PeoplePLOS ONE, 2008
- Agreement of self-reported estrogen use with prescription dataMenopause, 2008
- Hormone replacement therapy and cognitive performance in postmenopausal women—a review by cognitive domainNeuroscience & Biobehavioral Reviews, 2006
- Combined Postmenopausal Hormone Therapy and Cardiovascular Disease: Toward Resolving the Discrepancy between Observational Studies and the Women's Health Initiative Clinical TrialAmerican Journal of Epidemiology, 2005
- Age at Menopause, Cause-Specific Mortality and Total Life ExpectancyEpidemiology, 2005